In February, 10 IPOs raised a combined $2.0 billion, led by early debuts from a handful of $100+ million offerings. Deal flow was led by healthcare and senior facilities provider American Healthcare REIT (AHR) and Mexican discount grocer...read more
Several large issuers debuted in the US this past week, and four IPOs joined the pipeline. Sports equipment and apparel maker Amer Sports (AS) priced below the range to raise $1.3 billion at a $6.4 billion market cap. The Finland-based...read more
Fractyl Health, which is developing a medical device and other therapies for type 2 diabetes and obesity, raised $110 million by offering 7.3 million shares at $15, within the range of $14 to $16. Fractyl Health is a metabolic therapeutics company focused on...read more
Fractyl Health, which is developing a medical device and other therapies for type 2 diabetes and obesity, announced terms for its IPO on Monday. The Lexington, MA-based company plans to raise $110 million by offering 7.3 million shares at a price range of $14...read more
Renaissance Capital's February IPO Market Update
In February, 10 IPOs raised a combined $2.0 billion, led by early debuts from a handful of $100+ million offerings. Deal flow was led by healthcare and senior facilities provider American Healthcare REIT (AHR) and Mexican discount grocer...read more
US IPO Weekly Recap: Amer Sports’ billion-dollar US IPO leads a week of large listings
Several large issuers debuted in the US this past week, and four IPOs joined the pipeline. Sports equipment and apparel maker Amer Sports (AS) priced below the range to raise $1.3 billion at a $6.4 billion market cap. The Finland-based...read more
Diabetes and obesity-focused Fractyl Health prices IPO at $15 midpoint
Fractyl Health, which is developing a medical device and other therapies for type 2 diabetes and obesity, raised $110 million by offering 7.3 million shares at $15, within the range of $14 to $16. Fractyl Health is a metabolic therapeutics company focused on...read more
Diabetes and obesity-focused Fractyl Health sets terms for $110 million IPO
Fractyl Health, which is developing a medical device and other therapies for type 2 diabetes and obesity, announced terms for its IPO on Monday. The Lexington, MA-based company plans to raise $110 million by offering 7.3 million shares at a price range of $14...read more